| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |